Drug Profile
DTaP-poliovirus vaccine adult - Sanofi
Alternative Names: Adacel Quadra; Adacel-Polio; RepevaxLatest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Developer Sanofi
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 30 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 09 Aug 2004 Launched for Diphtheria (Prevention, In children, In adolescents) in United Kingdom (IM, Injection)